The blast has invested millions and taken a collegiate and collaborative approach with OTAT & Krause etc for this company making resubmission. Sit back and relax blasters. With this regulatory blockage starting to unwind, plenty of value about to be unlocked in the next 6-18 months for Rem-l with trials for ARDS and crohns/UC able to meaningfully progress.
Giddy up!
Ann: Submits New Information to FDA IND File for SR-aGVHD, page-17
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |